Since March, over 400 US colleges and universities have announced students get Covid-19 vaccinations, ahead of the Autumn semester but those who have been inocu
US students who took India s Covaxin, Russia s Sputnik V, asked to get re-vaccinated ANI | Updated: Jun 04, 2021 10:38 IST
Washington [US], June 4 (ANI): Since March, over 400 US colleges and universities have announced students get Covid-19 vaccinations, ahead of the Autumn semester but those who have been inoculated with India s indigenous Covaxin or the Russian-made Sputnik V are being asked to re-vaccinate as these vaccines have not yet been approved by the World Health Organization (WHO).
Rukmini Callimachi reports in the The New York Times that Milloni Doshi, a 25-year-old student from India, who is due to start her master s degree this fall at Columbia University s School of International and Public Affairs, has been administered two doses of Covaxin. Now, Columbia has told her that she will need to be revaccinated with a different vaccine once she arrives on campus.
Why the world depends on India s vaccine production to beat COVID
India s reputation as the pharmacy of the world has been bruised by COVID vaccine shortages. However, vaccinating people in developing countries largely depends on getting Indian production back on track.
India has shipped millions of COVID vaccine doses around the world
India is a world leader in vaccine manufacturing, and Indian pharmaceutical companies supply more than 50% of global demand for different vaccines needed for global immunization problems.
Before COVID surged in India this spring, Indian vaccine manufacturers like the Serum Institute of India (SII) were supplying developing countries with coronavirus vaccine doses via the World Health Organization s COVAX program.
Ocugen Inc. and Bharat Biotech on Thursday (June 3, 2021) announced that they have entered into an amendment to their Co-development, Supply, and Commercialization Agreement to expand Ocugen's exclusive territory to commercialize Covaxin.